NYSEARCA:GBDV Global Beta Smart Income ETF (GBDV) Price, Holdings, & News → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free GBDV Stock Alerts $23.44 -0.40 (-1.68%) (As of 08/22/2022) Add Compare Share Share Today's Range$23.33▼$23.5550-Day Range$23.44▼$23.4452-Week Range$20.57▼$28.62Volume3,000 shsAverage Volume9,924 shsMarket Capitalization$7.03 millionAssets Under Management$7.03 millionDividend Yield3.33%Net Expense Ratio0.29% Stock AnalysisStock Analysis Get Global Beta Smart Income ETF alerts: Email Address GBDV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBDV ETF News HeadlinesOctober 15, 2022 | finance.yahoo.comGlobal Beta Smart Income ETF (GBDV)October 10, 2022 | marketwatch.comGlobal Smart Android TV Market Size 2022 with Analysis by Country, Sales, Growth Rate and Forecast to 2025| Research Report by Absolute ReportsApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.October 6, 2022 | seekingalpha.comLaunching The Factor Investing Hub: Beat The Market With Smart BetaOctober 4, 2022 | seekingalpha.comSMART Global Holdings, Inc. (SGH) Q4 2022 Earnings Conference CallOctober 3, 2022 | msn.com3SGH : Earnings Outlook For SMART Global HoldingsSeptember 21, 2022 | nasdaq.comBondBloxx Launches Target Duration ETFsSeptember 16, 2022 | marketwatch.comSmart Buildings Market Registered Substantial Growth CAGR of 12.6% by 2027, Analyzed by Key Players and Growth Opportunities | Report [119 Pages]April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.September 14, 2022 | nasdaq.comGAMCO Natural Resources, Gold & Income Trust's 5.20% Series A Cumulative Preferred Shares About To Put More Money In Your PocketSee More Headlines Receive GBDV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Beta Smart Income ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details Issuer Fund NameGlobal Beta Smart Income ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GBDV Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$7.03 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares300,000BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Global Beta Smart Income ETF ExpensesTypeGBDVNYSEARCA ETFsAll ETFsManagement Fee0.29%0.50%0.51%Other Expenses0.20%0.64%0.58%Total Expense0.49%0.74%0.70%Fee Waiver0.20%-0.68%-0.57%Net Expense0.29%0.58%0.58% Global Beta Smart Income ETF (GBDV)Full Holdings Details Similar ETFsDirexion MSCI Defensives Over Cyclicals ETFNYSEARCA:RWDCIQ 50 Percent Hedged FTSE Japan ETFNYSEARCA:HFXJDeltaShares S&P EM 100 & Managed Risk ETFNYSEARCA:DMREIQ Enhanced Core Bond U.S. ETFNYSEARCA:AGGEPrincipal Ultra-Short Active Income ETFNYSEARCA:USI GBDV ETF - Frequently Asked Questions How have GBDV shares performed in 2024? Global Beta Smart Income ETF's stock was trading at $23.44 at the start of the year. Since then, GBDV shares have increased by 0.0% and is now trading at $23.44. View the best growth stocks for 2024 here. What is the management fee for Global Beta Smart Income ETF? Global Beta Smart Income ETF's management fee is 0.29% and has other expenses of 0.20%. However, GBDV has a fee waiver of 0.20% to reimburse the expenses. The net expense ratio for GBDV is 0.29%. How do I buy shares of Global Beta Smart Income ETF? Shares of GBDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:GBDV) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Beta Smart Income ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.